Emmaus Life Sciences, Inc. (EMMA) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $12.45M | -25.2% |
| 2024 | $16.65M | -43.7% |
| 2023 | $29.60M | +60.9% |
| 2022 | $18.39M | -10.8% |
| 2021 | $20.61M | -11.0% |
| 2020 | $23.17M | +1.8% |
| 2019 | $22.75M | +38.2% |
| 2018 | $16.46M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $12.45M | -25.2% |
| 2024 | $16.65M | -43.7% |
| 2023 | $29.60M | +60.9% |
| 2022 | $18.39M | -10.8% |
| 2021 | $20.61M | -11.0% |
| 2020 | $23.17M | +1.8% |
| 2019 | $22.75M | +38.2% |
| 2018 | $16.46M | — |